Page 31 - Revol11
P. 31

Liberman R y Kopellwicz A. Un enfoque empírico de la recuperación de la esquizofrenia: definir la recuperación e identificar los factores
que pueden facilitarla

 62. Lehman AF, Steinwachs DM, and PORT Co-investigators: Trans-              86. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe
      lating research into practice. The schizophrenia patient outcomes            performance. Br J Psychiatry 1991; 158:340-5.
      research team (PORT) treatment recommendations. Schizophr
      Bull 1998; 24:1-10.                                                     87. Strauss M. Relations of symptoms to cognitive deficits in schi-
                                                                                   zophrenia. Schizophr Bull 1993; 19:215-32.
 63. Scott JE, Dixon LB. Psychological interventions for schizophre-
      nia. Schizophr Bull 1995; 21:621-30.                                    88. Hammer MA, Katsanis J, Iacono WG, The relationship between
                                                                                   negative symptoms and neuropsychological performance. Biol
 64. Mueser KT, Bond GR. Psychosocial treatment approaches for                     Psychiatry 1995; 37:828-30.
      schizophrenia. Current Opinion in Psychiatry 2000; 13:27-35.
                                                                              89. Gold S, Arndt S, Nopoulos P, O’Leary DS, Andreasen N. Longi-
 65. Gunderson JG. Patient/ therapist matching: a research evalua-                 tudinal study of cognitive function in first-episode and recent-
      tion. Am J Psychiatry 1978; 135:1193-7.                                      onset schizophrenia. Am J Psychiatry 1999; 156:1342-8.

 66. Lamb HR. One-to-one relationships with the long-term mentally            90. Johnsstone EC, MacMillan JF, Frith CD, Bennm DK, Crow TJ.
      ill: Issues in training professionals. Community Ment Health J               Further investigation of the predictors of outcome following first
      1988; 24:328-37.                                                             schizophrenic episodes. Br J Psychiatry 1990; 157:182-9.

 67. Dingman CW, McGlashan TH. Psychotherapy. En: Bellack AS,                 91. Van der Does AJ, Dingemans PM, Linszen DH, Nugter MA, Schol-
      editor. A Clinical Guide for the Treatment of Schizophrenia.                 te WF. Symptoms dimensions and cognitive and social functioning
      Nueva York, NY: Plenum Press,1989; p. 263-82.                                in recent-onset schizophrenia. Psychol Med 1993; 23:745-53.

 68. Frank AF, Gunderson JG. The role of the therapeutic alliance in          92. Morrison RL, Bellack AS, Wixted JT, Mueser KT. Positive and
      the treatment of schizophrenia: Relationship to course and out-              negative symptoms in schizophrenia: A cluster-analytic approach.
      come. Arch Gen Psychiatry 1990; 47:228-36.                                   J Nerv Ment Dis 1990; 178:377-84.

 69. Kopelwicz A, Corrigan P, Wallace C, Liberman RP. Biopsychosocial         93. Lysaker P, Bell M. Negative symptoms and vocational impair-
      rehabilitation. En: Tasman A, Kay J, Lieberman JA, editors. Psy-             ment in schizophrenia: Repeated measurements of work per-
      chiatry. Philadelphia: W. B. Saunders Company, 1996; p. 1513-34.             formance over six months. Acta Psychiatr Scand 1995;
                                                                                   91:205-8.
 70. Liberman RP, Hilty DM, Drake RE, Tsang HWH. Requirements
      for multidisciplinary teamwork in psychiatric rehabilitation. Psy-      94. Kopelwicz A, Liberman RP, Mintz J, Zarate R. Efficacy of social
      chiatr Serv 2001; 52:1331-42.                                                skills training for deficit versus nondeficit negative symptoms in
                                                                                   schizophrenia. Am J Psychiatry 1997; 154:424-5.
 71. Hogarty GE, Goldberg SC, Schooler N. Drug and sociotherapy in
      the aftercare of schizophrenia patients. III. Adjustment of non-        95. McGlashan TH. A selective review of recent North American
      relapsed patients. Arch Gen Psychiatry 1974; 31:609-18.                      long-term follow-up studies of schizophrenia. Schizophr Bull
                                                                                   1988; 14:515-42.
 72. Gunderson JG, Frank AF, Katz HM, Vannicelli ML, Frosch JP,
      Knapp PH. Effects of psychotherapy in schizophrenia: II. Compa-         96. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geis-
      rative outcome of two forms of treatment. Schizophr Bull 1984;               ler S, et al. Predictors of relapse following response from a first
      10:564-98.                                                                   episode of schizophrenia or schizoaffective disorder. Arch Gen
                                                                                   Psychiatry 1999; 56:241-7.
 73. Spaniol L, Koehler M. The Experience of Recovery. Center for
      Psychiatric Rehabilitation: Boston University, 1994.                    97. Bland RC. Predicting the outcome in schizophrenia. Can J Psy-
                                                                                   chiatry 1982; 27:52-62.
 74. Nuechterlein KH, Subotnik KL, Gitlin M, Dawson ME, Ventura
      J, Snyder KS, et al. Neurocognitive and environmental contribu-         98. Heinssen RK, Liberman RP, Kopelowicz A. Psychosocial skills
      tors to work recovery after initial onset of schizophrenia: Answers          training for schizophrenia: Lessons from the laboratory. Schi-
      from path analyses. Schizophr Res 1999; 36:179.                              zophr Bull 2000; 26:21-46.

 75. Green MF. What are the functional consequences of neurocogni-            99. Wolkow KE, Ferguson H. Community factors in the develop-
      tive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-30.            ment of resiliency. Community Ment Health J 2001; 37:489-98.

 76. Gold JM, Bryant NL, Vladar K, Buchanan RW. Successful voca-             100. Wallace CJ, Liberman RP. Social skills training for patients with
      tional functioning in schizophrenia. Schizophr Res 1997; 24:222.             schizophrenia: A controlled clinical trial. Psychiatry Res 1985;
                                                                                   15:239-47.
 77. Kopelwicz A, Liberman RP. Biobehavioral treatment and rehabi-
      litation of persons with serious mental illness, En: Scotti JR edi-    101. Marder SR, Wirshing WC, Mintz K, McKenzie J. Two-year out-
      tor. New Directions in Behavioral Interventions: Principles,                 come of social skills training and group psychotherapy for outpa-
      Models, and Practices. Baltimore, MD: Brookes Publishing Com-                tients with schizophrenia. Am J Psychiatry 1996; 153:1585-92.
      pany, 1999, p. 103-28.
                                                                             102. Glynn SM, Mader SR, Liberman RP, Blair K, et al. Supplementing
 78. Lieberman RP: Cognitive remediation in schizophrenia. En Kas-                 clinic based skills training for schizophrenia with manualized
      hima H, Mizuno M, editors. Comprehensive Treatment of Schi-                  community support: Effects on social adjustment. [in press] Am J
      zophrenia: Linking Neurobehavioral Findings to Psychosocial                  Psychiatry.
      Approaches [in press]. Tokyo: Springer-Verlag, 2002.
                                                                             103. Liberman RP, Vaccaro JV, Corrigan PW. Psychiatric rehabilita-
 79. Lieberman RP, Gutkind D, Mintz J, Green M, Marshall BD, Ro-                   tion. En: Kaplan HI, Sadock BJ, editors. Comprehensive Textbo-
      bertson MJ. Impact of risperidona vs. haloperidol on activities of           ok of Psychiatry. Baltimore, MD: Williams & Wilkins, 1995.
      daily living on a social learning unit for treatment refractory schi-
      zophrenia.[in press]. Comprehensive Psychiatry, 2002.                  104. Penn DL, Meuser KT. Research update on the psychosocial treat-
                                                                                   ment of schizophrenia. Am J Psychiatry 1996; 153:607-17.
 80. Bond GR, Becker DR, Drake RE, Rapp CA, Meisler N, Lehman
      AF, et al. Implementing supported employment as an evidence-           105. Goldstein MJ. Psychosocial treatments for individuals with schi-
      based practice. Psychiatr Serv 2001; 52:313-22.                              zophrenia and related disorders. En: Miller NE, Magruder KM,
                                                                                   editors. Cost-effectiveness of psychotherapy: A guide for practi-
 81. Pogue-Geile MF, Harrow M. The longitudinal study of negative                  tioners, researchers, and policymakers. Nueva York: Oxford Uni-
      symptoms in schizophrenia. En: Grinker RR, Harrow M, editors.                versity Press, 1999; p. 235-47.
      Clinical Research in Schizophrenia: A multidimensional appro-
      ach. Springfield, IL: Charles C Thomas, 1987; p. 189-99.               106. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald
                                                                                   DP, Jarna CD, et al. Family psychoeducation, social skills trai-
 82. Buchanan RW, Gold, JM. Negative symptoms: diagnosis, treatment                ning, and maintenance chemotherapy in the aftercare treatment
      and prognosis. Intern Clin Psychopharmacol 1996; (Suppl 2): 3-11.            of schizophrenia. Arch Gen Psychiatry 1986; 43:633-42.

 83. Davidson L, McGlashan TH. The varied outcomes of schizophre-            107. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald
      nia. Can J Psychiatry 1997; 42:34-43.                                        DP, Ulrich RF, et al. Family psychoeducation, social skills trai-
                                                                                   ning, and maintenance chemotherapy in the aftercare treat-
 84. Glynn SM. Psychopathology and social functioning in schizoph-                 ment of schizophrenia: II. Two-year effects of a controlled
      renia. En: Mueser KT, Tarrier N, editors. Psychosocial functio-              study on relapse and adjustment. Arch Gen Psychiatry 1991;
      ning in schizophrenia. Allyn & Bacon; Boston:1998; p. 66-78.                 48:340-7.

 85. Fenton WS, McGlashan TH. Antecedents, symptom progression,              108. Stein LJ, Santos LB. Assertive community treatment of persons
      and long-term outcome of the deficit syndrome in schizophrenia.              with severe mental illness. Nueva York: Norton, 1998.
      Am J Psychiatry 1994; 151:351-6.

28 Rehabilitación psicosocial 2004; 1(1):12-29
   26   27   28   29   30   31   32   33   34   35   36